dr. nadler discusses role of pd-l1 in squamous nsclc
Published 5 years ago • 113 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:21
dr. nadler on the impact of immunotherapy in squamous nsclc
-
1:42
dr. nadler discusses the impower131 study in squamous nsclc
-
1:02
dr. gubens discusses the role of pd-l1 in patients with nsclc
-
3:22
the significance of pd-l1 expression in nsclc
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
1:55
dr. hirsch on value of pd-l1 testing in patients with lung cancer
-
10:20
pd-l1 testing in advanced lung cancer
-
1:53
dr. garassino discusses pros with durvalumab by pd-l1 expression in stage iii nsclc
-
2:20
dr. john haanen on the role of pd-l1 in lung cancer
-
3:50
pd-l1 expression in nsclc
-
0:56
pembrolizumab and the significance of pd-l1 for lung cancer
-
1:25
the future role of pd-l1 testing in lung cancer
-
12:59
case based panel discussion - adv non squamous nsclc, low pd-l1 no mutation - best systemic therapy?
-
0:54
dr. bestvina on the keynote-407 trial in squamous nsclc
-
9:21
case based panel discussions - metastatic squamous nsclc low tumor pd-l1 frail patient - treatment?
-
5:02
dr blythe adamson: pd-l1 as a predictive biomarker in lung cancer continues to evolve
-
1:21
poet: the predictive and prognostic value of pd-l1 expression in nsclc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:34
dr. spigel discusses pd-l1 antibody for non-small cell lung cancer patients - sarah cannon